Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme

Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme

Abstract Background Adverse effects of antileishmanial drugs can affect patients’ quality of life and adherence to therapy for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). In Bangladesh, there are 26 treatment centers that manage leishmaniasis cases coming from 100 end...

Full description

Bibliographic Details
Main Authors: Md. Sakhawat Hossain, Amresh Kumar, A.F.M Akhtar Hossain, Md. Mahshin, Abhijit Sharma, Md. Akter Hossain, Varun Sharma, Rashidul Haque, A.K.M Shamsuzzaman, Shomik Maruf, Prakash Ghosh, Vivek Ahuja, Dinesh Mondal
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Infectious Diseases of Poverty
Subjects:
Visceral leishmaniasis
Pharmacovigilance
Antileishmanial drugs
Health system
Bangladesh
Online Access:http://link.springer.com/article/10.1186/s40249-018-0461-0

Internet

http://link.springer.com/article/10.1186/s40249-018-0461-0

Similar Items